PubMed1988
Osteoarthritic changes in the knee are often a late result of total meniscectomy. In cases of total resection, availability of a prosthetic meniscus might limit development of these changes. The objective of this research was to evaluate a glutaraldehyde-cross-linked medial meniscus as a morphologically and biologically compatible prosthesis in a canine model. Medial and lateral menisci were harvested from donor dogs, frozen in saline, and cross-linked with glutaraldehyde. Five host animals were selected and matched with donors. Glutaraldehyde-cross-linked medial menisci were implanted bilaterally in the stifle joints and one glutaraldehyde cross-linked lateral meniscus was implanted subcutaneously. Clinical results showed asymptomatic limb and joint usage during the 12 postoperative weeks. Gross and histological evaluations indicated acceptable biocompatibility. The subcutaneous implants were encapsulated with a thin fibrous tissue capsule that was only mildly inflamed. Within the joints, the anterior attachment and periphery were maintained in position by their sutures; however, there was dehiscence of the posterior suture in all cases. The articulating surfaces of the implants were intact. There was an initial loss in the quantity of proteoglycans following glutaraldehyde treatment, with significant recovery after implantation into the joints. There were significant degenerative changes (loss of proteoglycans and fibrillation) in the articular cartilage on the femoral condyle and tibial plateau most likely a result of the posterior attachment failure. It was concluded that glutaraldehyde-cross-linked meniscal allografts showed an acceptable degree of histocompatibility. However, failure of the posterior attachment interfered with testing the efficacy of the prosthesis.(ABSTRACT TRUNCATED AT 250 WORDS)